Clinical trial
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
NCT00006171 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006171 |
|---|---|
| Title | Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma |
| Official title | A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Seropositivity, Kaposi's Sarcoma, HIV Infections |
| Enrollment | 24 |
| Start date | Aug 7, 2000 |
| Completion | Jun 29, 2012 |
| First posted | Aug 11, 2000 |
| Last update posted | Dec 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: